R A KRAUSE
Overview
Explore the profile of R A KRAUSE including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
32
Citations
91
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Fey T, KRAUSE R, Hsieh G, Andrews J, Bretheim P, Morgan S, et al.
J Pharmacol Toxicol Methods
. 1998 May;
39(1):9-17.
PMID: 9596143
The rodent heterotopic ear-heart transplant method is a useful alternative to the more technically demanding vascularized graft technique. We modified the procedure to improve efficiency and used it in mice...
3.
Mollison K, Fey T, KRAUSE R, Andrews J, Bretheim P, Cusick P, et al.
Toxicology
. 1998 May;
125(2-3):169-81.
PMID: 9570331
The nephrotoxic potential of ascomycin, the C21-ethyl analogue of FK506, was defined and ways explored to enhance its detection. After 14-day dosing in the Fischer-344 rat, FK506 and ascomycin reduced...
4.
Mollison K, Fey T, KRAUSE R, Andrews J, Bretheim P, Brandt J, et al.
J Pharmacol Exp Ther
. 1998 Feb;
283(3):1509-19.
PMID: 9400028
Comparing nephrotoxicity of numerous drug analogs is impractical with chronic in vivo models. We devised a new cisplatin potentiation assay (CISPA) that sensitively detects renal injury as a serum creatinine...
5.
Mollison K, Andrews J, Fey T, Miller L, KRAUSE R, Bretheim P, et al.
Transplant Proc
. 1996 Dec;
28(6):3185-8.
PMID: 8962236
No abstract available.
6.
Mollison K, Fey T, KRAUSE R, Thomas V, Mehta A, Luly J
Ann N Y Acad Sci
. 1993 Jun;
685:55-7.
PMID: 7689812
No abstract available.
7.
Burres N, Premachandran U, Frigo A, Swanson S, Mollison K, Fey T, et al.
J Antibiot (Tokyo)
. 1991 Dec;
44(12):1331-41.
PMID: 1723403
The immunosuppressive effects of the dunaimycins, a new complex of spiroketal 24-membered macrolides, were compared to cyclosporin A, ascomycin, and rapamycin. Each dunaimycin was a potent inhibitor of the mitogenic...
8.
Mollison K, Fey T, KRAUSE R, Miller L, Edalji R, Conway R, et al.
Agents Actions Suppl
. 1991 Jan;
35:17-21.
PMID: 1664187
A number of C5a modifications were tested to determine effects on receptor binding to polymorphonuclear leukocyte (PMNL) membrane receptors and triggering of PMNL chemokinesis and myeloperoxidase (MPO) release. Site-directed mutagenesis...
9.
Mollison K, Mandecki W, Zuiderweg E, Fayer L, Fey T, KRAUSE R, et al.
Proc Natl Acad Sci U S A
. 1989 Jan;
86(1):292-6.
PMID: 2643101
C5a is an inflammatory mediator potentially involved in a number of diseases. To help define which of its 74 residues are important for receptor binding and response triggering, changes in...
10.
Mollison K, Fey T, KRAUSE R, Mandecki W, Fox J, Carter G
Agents Actions
. 1987 Aug;
21(3-4):366-70.
PMID: 3318320
Poor expression of a synthetic gene for the inflammatory mediator, C5a, was observed in E. coli grown in rich media. Varying the media composition markedly improved expression, although C5a levels...